Navigation Links
Spectranetics Introduces New Device for Removal of Non-Functional and Infected Cardiac Leads
Date:5/15/2008

LLD EZ(TM) Provides Physicians with Flexibility and Control for Lead

Removal

COLORADO SPRINGS, Colo., May 15 /PRNewswire-FirstCall/ -- Spectranetics Corporation (Nasdaq: SPNC) today announced the availability of the new LLD EZ Lead Locking Device (LLD) for the removal of non-functional or infected pacing and defibrillation leads. The LLD EZ enables physicians to secure the entire lead creating traction to enable the removal process.

Management of implanted leads for pacemakers and defibrillators is a growing concern among physicians and patients since an increasing number of patients receive these devices at a relatively young age. Leads, or insulated wires that connect devices to the heart, may become non-functional or infected. When this occurs the primary treatment option is to remove the leads. Because scar tissue can bind the leads in several places along their length, specialized tools are needed to complete the removal process.

Spectranetics' LLD EZ provides a flexible solution to address the removal of leads from scar tissue holding them in place. LLD EZ employs a braided mesh that expands to secure leads along their hollow inner lumen permitting physicians to apply steady traction on the lead. The locking mechanism can be reversed, or unlocked, if the physician needs to remove the device from the lead or reposition it. The LLD EZ provides versatility to remove a wide range of pacing and defibrillation lead sizes.

"Controlling the entire lead length throughout the removal process is important for achieving safe and complete removal. The LLD technology gives me this control; it's a feature that other tools don't offer," said Dr. Laurence Epstein, Chief of Cardiac Arrhythmia Services, Brigham and Women's Hospital in Boston. "The design of the LLD EZ makes it easy to incorporate this tool into my cases."

LLD EZ also features an enhanced tip design and sleek profile to facilitate tracking and passage of the device through tight curves and beyond lumen damage. The specialized tip is radiopaque, enabling verification of tip location under fluoroscopy. Additionally, a new low-profile handle design permits easy loading of extraction sheaths. Spectranetics' Lead Locking Device technology is often used in conjunction with Spectranetics' Laser Sheath, or SLS II, which employs "cool" ultraviolet light known as excimer laser to dissolve the scar tissue binding the leads.

"Increasingly, lead removal is the best decision for many of my patients when lead issues are encountered. The LLD EZ fits the majority of leads making device selection easy," said Dr. Roger Carrillo, a cardiothoracic surgeon at Mount Sinai Medical Center in Miami. "With the sleek tip design, the LLD EZ simplifies navigation and manipulation."

Spectranetics' LLD EZ is currently available in the United States and Canada and is a variant of the Company's LLD E device, which received clearance from the Food and Drug Administration in March 2005. For additional information or to purchase the LLD EZ, please visit http://www.spectranetics.com.

About Spectranetics

Founded in 1984, Spectranetics manufactures and sells the only excimer laser approved in the United States, Europe and Japan for use in minimally invasive cardiovascular procedures. This technology treats complex cardiovascular conditions by photo-ablating multiple lesion types into tiny particles that are easily absorbed into the blood stream. The Company's disposable catheters use high-energy "cool" ultraviolet light to vaporize arterial blockages in the legs and heart, as well as scar tissue encapsulating pacing and defibrillation leads. For more information, visit http://www.spectranetics.com.

Stacey Holifield/Kate Finigan

Schwartz Communications, Inc.

(781) 684-0770

spectranetics@schwartz-pr.com


'/>"/>
SOURCE Spectranetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Spectranetics to Present at The A.G Edwards Growth Conference on September 18
2. Spectranetics to Appeal Decision in Patent Litigation
3. Spectranetics Receives Reimbursement Approval in Belgium for Lead Removal and Peripheral Atherectomy Products
4. Spectranetics to Hold 2007 Third Quarter Financial Results Conference Call on October 31
5. Spectranetics Announces Clinical Data From Cello Trial
6. Delta Dental of Illinois Introduces Smile Smart For Your Health
7. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
8. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
9. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
10. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
11. Triveris Introduces Personal Health Record with Built-in Health Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... consulting firm servicing communities throughout the greater Cincinnati metropolitan area, is teaming up ... temporary lodgings for families with children receiving treatment in nearby hospitals. , Ronald ...
(Date:6/27/2017)... London UK (PRWEB) , ... June 27, 2017 , ... ... a clinical study is whether they can trust the sponsor to pay them correctly ... vital that sponsors and CROs establish payment strategies that encourage sites to work on ...
(Date:6/27/2017)... ... , ... The Congressional Budget Office (CBO) projects that the Better Care Reconciliation ... and Affordable Care Act (ACA), would result in 22 million Americans losing their health ... More than 20 million Americans have gained health insurance under the ACA, and from ...
(Date:6/27/2017)... ... 27, 2017 , ... A January 18th article on medGadget reports ... billion by the year 2024 according to a new report. The article also notes ... from titanium. Los Angeles area clinic Beverly Hills Periodontics & Dental Implant Center says ...
(Date:6/27/2017)... New York, NY (PRWEB) , ... June 27, ... ... communications and marketing experts to contribute to an upcoming case studies guidebook. This ... or her organization. , This book will include articles, case studies and how-to’s ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)... -- Exactly 50 years ago today, the Monterey Pop Festival opened ... the San Francisco "Summer of Love."  To celebrate the anniversary, ... in strategic market research portals that it will begin delivering ... Northern Light,s "Summer of Love (For Our Customers)."  ... ...
(Date:6/14/2017)... , June 14, 2017  In 2016, Embodied ... Startups pitch competition and came away with $25,000 ... is described by Forbes as "entering the life of ... Association as teaching "empathy to medical professionals in an ... was recently named a finalist for the Department of ...
(Date:6/11/2017)...  Eli Lilly and Company (NYSE: LLY ) ... of galcanezumab, an investigational treatment for the prevention of ... key secondary endpoints for galcanezumab compared to placebo at ... EVOLVE-2 and REGAIN) will be presented today at the ... Boston . "The detailed ...
Breaking Medicine Technology: